Handbook of Clinical medicine

Gram-negative bacilli Aminoglycoside IV + antipseudomonal Pseudomonas penicillin IV or 3rd-generation cephalosporin Anaerobes IV (p387) Aspiration Streptococcus pneumoniae Cephalosporin IV + metronidazole IV Anaerobes Neutropenic patients Gram-positive cocci Aminoglycoside IV + antipseudomonal peni- Gram-negative bacilli cillin IV or 3rd-generation cephalosporin IV Fungi (p177) Consider antifungals after 48h Pneumococcal vaccine At-risk groups: • All adults ≥ 65yrs old. • Chronic heart, liver, renal, or lung conditions. • Diabetes mellitus not controlled by diet. • Immun o sup pression, eg spleen function, AIDS, or on chemotherapy or prednis- olone >20mg/d, cochlear implant, occupation risk (eg welders), CSF fl uid leaks. Vaccinate every 5yrs. CI: Pregnancy, lactation, T°, previous anaphylaxis to vaccine or one of its com- ponents. __OOHHCCMM__1100ee..iinnddbb 116677 0022//0055//22001177 1199::0077 enicidem tsehC 168 Specifi c pneumonias Pneumococcal pneumonia The commonest bacterial pneumonia. Aff ects all ages, but is commoner in the elderly, alcoholics, post-splenectomy, immunosuppressed, and patients with chronic heart failure or pre-existing lung disease. Clinical fea- tures: Fever, pleurisy, herpes labialis. CXR shows lobar consolidation. If mod/severe check for urinary antigen. Treatment: amoxicillin, benzylpenicillin, or cephalosporin. Staphylococcal pneumonia May complicate infl uenza infection or occur in the young, elderly, intravenous drug users, or patients with underlying disease, eg leu- kaemia,
